Beam Therapeutics Inc. (BEAM)
USD 26.45
(-7.45%)
USD 26.45
(-7.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 377.7 Million | 60.92 Million | 51.84 Million | 24 Thousand | 18 Thousand | - |
| Cost of Revenue | 437.38 Million | 22.57 Million | 16.44 Million | 103.17 Million | 5.4 Million | 650 Thousand |
| Gross Profit | -59.67 Million | 38.34 Million | 35.4 Million | -103.15 Million | -5.38 Million | -650 Thousand |
| Operating Expenses | 554.19 Million | 399.39 Million | 444.3 Million | 132.78 Million | 75.17 Million | 45.74 Million |
| Selling, General and Administrative Expenses | 116.81 Million | 87.8 Million | 57.22 Million | 29.6 Million | 20.55 Million | 11.86 Million |
| Research and Development Expenses | 437.38 Million | 311.59 Million | 387.08 Million | 103.17 Million | 54.61 Million | 33.87 Million |
| Other Expenses | - | - | - | - | -71 Thousand | -10.04 Million |
| Cost and Expenses | 554.19 Million | 399.39 Million | 444.3 Million | 132.78 Million | 75.17 Million | 45.74 Million |
| Operating Income | -176.48 Million | -338.47 Million | -392.46 Million | -132.76 Million | -75.15 Million | -45.74 Million |
| Interest Expense | - | 15.29 Million | 9000.00 | 1.56 Million | 187 Thousand | - |
| Income Tax Expense | 1.36 Million | 3.41 Million | -29.27 Million | 61.83 Million | 116 Thousand | -70.99 Million |
| Earnings before Tax | -131.16 Million | -260.17 Million | -370.63 Million | -194.59 Million | -78.32 Million | -116.73 Million |
| Net Income | -132.52 Million | -263.58 Million | -341.36 Million | -256.42 Million | -78.44 Million | -115.25 Million |
| Earnings Per Share Basic | -1.72 | -3.76 | -5.31 | -5.49 | -1.53 | -3.28 |
| Earnings Per Share Diluted | -1.72 | -3.76 | -5.31 | -5.49 | -1.53 | -3.28 |
| Weighted Average Shares Outstanding | 77.15 Million | 70.01 Million | 64.22 Million | 46.73 Million | 51.33 Million | 35.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 77.15 Million | 70.01 Million | 64.22 Million | 46.73 Million | 51.33 Million | 35.13 Million |
| Gross Margin | -0.16 | 0.63 | 0.68 | -4298.12 | -299.39 | - |
| EBIT Margin | -0.41 | -6.59 | -7.99 | -2692.71 | -3846.44 | - |
| Profit Margin | -0.35 | -4.33 | -6.58 | -10.68 Thousand | -4357.89 | - |
| EBITDA | -156.47 Million | -324.33 Million | -392.46 Million | -128.02 Million | -71.65 Million | -45.09 Million |
| Earnings Before Tax Margin | -0.47 | -5.56 | -7.57 | -5531.67 | -4175.22 | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 14.26 Million | 11.77 Million | 7.41 Million | 377.7 Million | 316.19 Million | 17.19 Million |
| Cost of Revenue | - | 5.57 Million | 5.43 Million | 20.01 Million | 5.36 Million | 7.47 Million |
| Gross Profit | 14.26 Million | 6.19 Million | 1.97 Million | 357.69 Million | 310.83 Million | 9.71 Million |
| Operating Expenses | 120.77 Million | 111.09 Million | 106.11 Million | 534.18 Million | 177.97 Million | 125.46 Million |
| Selling, General and Administrative Expenses | 26.51 Million | 24.05 Million | 21.29 Million | - | 37.89 Million | 25.41 Million |
| Research and Development Expenses | 94.25 Million | 87.04 Million | 84.81 Million | - | 140.07 Million | 100.05 Million |
| Other Expenses | - | -87.04 Million | - | - | - | - |
| Cost and Expenses | 120.77 Million | 116.66 Million | 111.54 Million | 554.19 Million | 183.33 Million | 125.46 Million |
| Operating Income | -106.5 Million | -104.89 Million | -104.13 Million | -176.48 Million | 132.85 Million | -108.26 Million |
| Interest Expense | 12.12 Million | 14.19 Million | - | 46.67 Million | 12.06 Million | 12.69 Million |
| Income Tax Expense | - | 39 Thousand | 5.38 Million | 1.36 Million | 1.36 Million | -17.36 Million |
| Earnings before Tax | -96.66 Million | -91.01 Million | -98.66 Million | -131.16 Million | 144.16 Million | -96.08 Million |
| Net Income | -96.66 Million | -91.05 Million | -98.66 Million | -132.52 Million | 142.79 Million | -96.08 Million |
| Earnings Per Share Basic | -1.17 | -1.11 | -1.21 | - | 1.77 | -1.22 |
| Earnings Per Share Diluted | -1.17 | -1.11 | -1.21 | - | 1.73 | -1.22 |
| Weighted Average Shares Outstanding | 82.41 Million | 82.31 Million | 81.69 Million | 77.15 Million | 80.85 Million | 79.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 82.41 Million | 82.31 Million | 81.69 Million | 77.15 Million | 82.7 Million | 79.02 Million |
| Gross Margin | 1.00 | 0.53 | 0.27 | 0.95 | 0.98 | 0.57 |
| EBIT Margin | -7.46 | -8.44 | -13.32 | - | 0.44 | -6.27 |
| Profit Margin | -6.77 | -7.73 | -13.32 | -0.35 | 0.45 | -5.59 |
| EBITDA | -106.5 Million | -99.31 Million | -98.7 Million | - | 138.22 Million | -107.74 Million |
| Earnings Before Tax Margin | -7.46 | -8.91 | -14.05 | -0.47 | 0.42 | -6.30 |
GYG
1368
CAMPUS
8956
0279
8519